XML 43 R34.htm IDEA: XBRL DOCUMENT v3.23.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
performanceObligation
system_option
Sep. 30, 2022
Sep. 30, 2023
performanceObligation
system_option
Sep. 30, 2022
Dec. 31, 2022
Jan. 01, 2023
USD ($)
Summary Of Significant Accounting Policies [Line Items]            
Proposed national payments rates 0.05          
Number of Zio system options | system_option 3   3      
Number of performance obligations | performanceObligation 2   2      
Federal Government Agencies | Revenue | Customer Concentration Risk            
Summary Of Significant Accounting Policies [Line Items]            
Concentration of credit risk (as a percent) 25.00% 26.00% 25.00% 24.00%    
Federal Government Agencies | Accounts Receivable | Accounts Receivable Concentration Risk            
Summary Of Significant Accounting Policies [Line Items]            
Concentration of credit risk (as a percent)     22.00%   22.00%  
Product And Services Zio X T Service Code93247            
Summary Of Significant Accounting Policies [Line Items]            
Reimbursement rate           $ 243.65
Product And Services Zio X T Service Code93247 | Minimum            
Summary Of Significant Accounting Policies [Line Items]            
Estimated reimbursement rate           247.59
Product And Services Zio X T Service Code93247 | Maximum            
Summary Of Significant Accounting Policies [Line Items]            
Estimated reimbursement rate           334.46
Product And Services Zio X T Service Code93243            
Summary Of Significant Accounting Policies [Line Items]            
Reimbursement rate           231.79
Product And Services Zio X T Service Code93243 | Minimum            
Summary Of Significant Accounting Policies [Line Items]            
Estimated reimbursement rate           235.54
Product And Services Zio X T Service Code93243 | Maximum            
Summary Of Significant Accounting Policies [Line Items]            
Estimated reimbursement rate           $ 318.17